BAWAG GROUP AG/ AT0000BAWAG2 /
21.06.2024 8:09:56 | Изменение +0.80 | Объем сделки | Бид17:36:41 | Предложение17:36:41 | Рыночная капитализация | Дивидендная доходность | Коэффициент Цена/Доход |
---|---|---|---|---|---|---|---|
59.70EUR | +1.36% | 0 Оборот: 0.00 |
-Величина цены спроса: - | -Величина цены предложения: - | 4.62 млрдEUR | 8.50% | 7.30 |
GlobeNewswire
1:15
Crown Crafts to Announce Fourth Quarter and Full Year Fiscal 2024 Results on June 28, 2024
GlobeNewswire
1:10
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AAN, RPHM on Behalf of Shareholders
GlobeNewswire
0:45
Teladoc Health is Providing Free Virtual Health Care Services to New Mexico Residents Impacted by Wi...
GlobeNewswire
0:38
Toyota Announcement: If You Have Suffered Losses in Toyota Motor Corporation (NYSE: TM), You Are Enc...
GlobeNewswire
0:30
Terns Pharmaceuticals Highlights New Preclinical Data Supporting TERN-501 in Combination with a GLP-...
GlobeNewswire
0:24
Shareholder Alert: Robbins LLP Informs Stockholders of the Class Action Filed Against UiPath, Inc. (...
GlobeNewswire
0:00
KIP Protocol Partners with Open Campus to Launch Open Campus U, Transforming Education Through Decen...
GlobeNewswire
21.06
Antibody-drug Conjugates Shift the Cancer Treatment Landscape: Novotech Whitepaper Examines Latest C...
GlobeNewswire
21.06
Shareholder Alert: Robbins LLP Informs Stockholders of the Class Action Filed Against NIKE, Inc. (NK...
GlobeNewswire
21.06
NIKE, INC. (NYSE: NIKE) INVESTOR ALERT: Bernstein Liebhard LLP Announces that a Securities Class Act...
GlobeNewswire
21.06
Metasphere Labs Enters a Definitive Agreement with ARCannabis to Develop VR Virtual Store
GlobeNewswire
21.06
In Major Victory For Injured Owners of “Dangerously Defective” Firearm, Federal Jury Awards $2.35 Mi...
GlobeNewswire
21.06
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
GlobeNewswire
21.06
Goodness Growth Holdings Announces Voting Results of Annual General and Special Meeting of Sharehold...
- Первая страница
- Назад
- 1
- 2
- 3
- 4
- Следующий
- Последняя страница